cjc-1295 ipamorelin blend dosage protocol + Chart: 200–300 mcg/day CJC-1295 / Ipamorelin Peptide Therapy:

J Pulm Respir Med

Because results from CJC-1295 + Ipamorelin build gradually often over several weeks to a few months the delivery method youll actually stick with matters as much as the peptide itself

Ipamorelin + CJC-1295 Stack: Evidence, Mechanism, and Protocol At a glance Drug class / Growth hormone secretagogue (GHRP) + Growth hormone-releasing hormone analogue (GHRH analogue) Ipamorelin receptor target / Ghrelin receptor (GHSR-1a), selective, no cortisol or prolactin spike CJC-1295 receptor target / GHRH receptor (GHRHR) on pituitary somatotrophs Combination mechanism / GHRP + GHRH co-stimulation raises GH pulse amplitude 2-to-10-fold over either agent alone in animal models Typical ipamorelin dose / 100-300 mcg subcutaneous injection, 1-3x daily Typical CJC-1295 (no DAC) dose / 100-300 mcg subcutaneous injection, timed with ipamorelin Typical CJC-1295 with DAC dose / 1,000-2,000 mcg subcutaneous injection, once weekly Primary evidence level / Mechanistic + animal + one Phase II RCT (CJC-1295)

Also, it decreases redness and skin inflammation and is known to treat acne and stretch marks

Regular check-ins help your provider keep dosing in a comfortable range